PromiCell, Inc. presents during JP Morgan’s 2026 Healthcare Conference
MIAMI, FL, Jan 10, 2026 – (ACN Newswire via SeaPRwire.com) – PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s lead asset PRO CAR – 201A, […]





















